Skip to main content

GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise of protein-based therapies

We are redefining therapeutics by leveraging new protein building blocks to transform treatment for countless patients.

More About Us

Watch the Company Overview

The GRO Platform

The GRO platform expands the amino acid alphabet to overcome the limitations of protein therapeutics currently impeding the treatment of disease

We’re delivering on the long-awaited promise of protein therapeutics by solving the intrinsic limitations of proteins on potency, stability, and function. The GRO platform shortens development timelines and is the only system capable of seamlessly scaling production of NSAA (non-standard amino acid) proteins to meet clinical needs.

Solid GRO Bioscience Blue Circle
Gradient Circle
Science Woman
Gradient Circle Overlay

Our Pipeline

Today, we’re focused on our first two families of NSAA chemistries to drive our product pipeline

GRObio is advancing its first two families of NSAA chemistries to build its product pipeline. DuraLogic™ chemistries focus on therapeutic stability and dosing schedule, while ProGly™ chemistries provide biologics that reeducate the immune system to treat autoimmune disease, or to eliminate immunogenic side-effects of protein-based therapies.

Light Blue Solid Circle
Gradient Background Circle
Elderly Man with grandson
Gradient Circle Overlay

Featured News

October 10, 2023 in Featured News, News

Biorasi’s Few & Far Between Podcast: Breakthroughs in Protein Design – from Biocontainment to Creating a New Amino Acid Alphabet

In this episode, Biorasi CEO Chris O’Brien hosted scientist and entrepreneur Daniel J. Mandell, Ph.D. to discuss how his creativity and imagination led him on a journey to developing the…
Read More
September 27, 2023 in Featured News, Press Releases

GRO Biosciences Presents Preclinical Data on Two ProGly™ Programs for Non-Standard Amino Acid Therapies

- Data represent promising new modalities for reversing autoimmune disease without immunosuppression and for eliminating anti-drug antibodies against immunogenic therapies BOSTON, September 27, 2023 - GRO Biosciences Inc. (“GRObio”), an…
Read More
September 22, 2023 in Featured News, News Recoding Life Scientists have created an organism that defies the rules of biology by using nonstandard amino acids. And you probably have some questions. Katia Tarasava, PhD, interviewed our CEO Dan…
Read More